Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcomes:
The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.
Sign up for our free newsletter.
We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.
We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.
PRevious Issues
Genome Atlantic gratefully acknowledges the financial support of the Government of Canada through Genome Canada, as well as the Atlantic Canada Opportunities Agency and the provincial governments of Newfoundland and Labrador, Nova Scotia, New Brunswick, and Prince Edward Island.
Genome Atlantic is one of 7 Genome Centres in Canada that are part of the Genome Canada Enterprise. This network encourages collaboration, with each centre focusing on the needs of their respective regions.
Site Navigation